T1	AdverseReaction 438 446	lymphoma
T2	AdverseReaction 457 469	malignancies
T3	DrugClass 514 526	TNF blockers
T4	AdverseReaction 542 555;570 579	Heart failure new onset
T5	Factor 580 583	may
T6	AdverseReaction 605 616	Anaphylaxis
T7	AdverseReaction 628 646	allergic reactions
T8	Severity 620 627	serious
T9	Factor 647 650	may
T10	AdverseReaction 894 915	Demyelinating disease
T11	Factor 944 947	may
T12	AdverseReaction 1333 1343	infections
T13	Severity 1325 1332	serious
T14	Factor 1305 1309	risk
T16	AdverseReaction 1422 1427	death
T17	Factor 1391 1394	may
T18	AdverseReaction 1433 1457	Opportunistic infections
T19	AdverseReaction 1447 1457;1465 1474	infections bacterial
T20	AdverseReaction 1447 1457;1476 1489	infections mycobacterial
T21	AdverseReaction 1447 1457;1491 1506	infections invasive fungal
T22	AdverseReaction 1447 1457;1508 1513	infections viral
T23	AdverseReaction 1447 1457;1515 1524	infections parasitic
T24	AdverseReaction 1569 1582	aspergillosis
T25	AdverseReaction 1584 1597	blastomycosis
T26	AdverseReaction 1599 1610	candidiasis
T27	AdverseReaction 1612 1630	coccidioidomycosis
T28	AdverseReaction 1632 1646	histoplasmosis
T29	AdverseReaction 1648 1661	legionellosis
T30	AdverseReaction 1663 1674	listeriosis
T31	AdverseReaction 1676 1690	pneumocystosis
T32	AdverseReaction 1695 1707	tuberculosis
T33	DrugClass 1732 1744	TNF blockers
T34	AdverseReaction 2167 2176	infection
T35	Factor 2159 2163	risk
T36	AdverseReaction 2666 2694	reactivation of tuberculosis
T37	AdverseReaction 2702 2725	tuberculosis infections
T38	AdverseReaction 5855 5867	malignancies
T39	DrugClass 5912 5924	TNF blockers
T40	AdverseReaction 6056 6068	malignancies
T41	AdverseReaction 6470 6482	Malignancies
T42	AdverseReaction 6489 6494	fatal
T43	DrugClass 6589 6608	TNF-blocking agents
T44	AdverseReaction 6716 6725	lymphomas
T45	AdverseReaction 6737 6744;6765 6773	Hodgkin lymphoma
T46	AdverseReaction 6751 6773	non-Hodgkin's lymphoma
T47	AdverseReaction 6826 6838	malignancies
T48	AdverseReaction 6852 6869	rare malignancies
T49	AdverseReaction 6916 6928	malignancies
T50	AdverseReaction 6992 7004	malignancies
T51	AdverseReaction 7435 7443	lymphoma
T52	DrugClass 7488 7500	TNF blockers
T53	AdverseReaction 7637 7645	lymphoma
T54	AdverseReaction 7698 7716	Hodgkin's lymphoma
T55	AdverseReaction 7854 7862	lymphoma
T58	AdverseReaction 8465 8473	lymphoma
T60	AdverseReaction 8683 8712	hepatosplenic T-cell lymphoma
T61	AdverseReaction 8714 8719	HSTCL
T62	AdverseReaction 8810 8815	fatal
T63	AdverseReaction 9500 9516	chronic leukemia
T64	AdverseReaction 9490 9495;9508 9516	acute leukemia
T65	DrugClass 9571 9582	TNF-blocker
T70	AdverseReaction 9991 10004	new onset CHF
T73	AdverseReaction 10241 10260	increased mortality
T74	AdverseReaction 10268 10271	CHF
T75	DrugClass 10183 10194	TNF blocker
T76	AdverseReaction 10496 10522	hypersensitivity reactions
T77	Factor 10471 10476	could
T78	AdverseReaction 10594 10604	angioedema
T79	AdverseReaction 10606 10613	dyspnea
T80	AdverseReaction 10615 10626	hypotension
T81	AdverseReaction 10628 10632	rash
T82	AdverseReaction 10634 10648	serum sickness
T83	AdverseReaction 10654 10663	urticaria
T84	AdverseReaction 11174 11207	reactivation of hepatitis B virus
T85	AdverseReaction 11285 11301	HBV reactivation
T86	DrugClass 11332 11343	TNF blocker
T87	AdverseReaction 11361 11366	fatal
T88	AdverseReaction 11522 11538	HBV reactivation
T89	AdverseReaction 12752 12796	central nervous system demyelinating disease
T90	AdverseReaction 12808 12826	multiple sclerosis
T91	AdverseReaction 12837 12869	peripheral demyelinating disease
T92	AdverseReaction 12881 12904	Guillain-Barre syndrome
T93	AdverseReaction 13079 13101	neurological disorders
T94	AdverseReaction 13113 13129	seizure disorder
T95	AdverseReaction 13131 13145	optic neuritis
T96	AdverseReaction 13151 13172	peripheral neuropathy
T97	AdverseReaction 13316 13328	pancytopenia
T98	AdverseReaction 13340 13355	aplastic anemia
T99	DrugClass 13381 13393	TNF blockers
T100	AdverseReaction 13395 13438	Adverse reactions of the hematologic system
T101	AdverseReaction 13472 13481	cytopenia
T102	AdverseReaction 13489 13499	leukopenia
T103	AdverseReaction 13501 13513	pancytopenia
T104	AdverseReaction 13515 13531	thrombocytopenia
T105	AdverseReaction 14278 14288	infections
T106	Severity 14270 14277	Serious
T107	DrugClass 14406 14416	etanercept
T109	AdverseReaction 14495 14505	infections
T110	Severity 14487 14494	serious
T111	Factor 14479 14483	risk
T112	DrugClass 14546 14558	TNF blockers
T113	AdverseReaction 15009 15028	lupus-like syndrome
T114	Factor 14927 14930	may
T117	AdverseReaction 226 252	Invasive fungal infections
T119	AdverseReaction 969 979	Cytopenias
T120	AdverseReaction 981 993	pancytopenia
T121	AdverseReaction 1113 1132	Lupus-like syndrome
T115	AdverseReaction 542 566	Heart failure, worsening
T116	AdverseReaction 672 702	Hepatitis B virus reactivation
T118	AdverseReaction 60 70	infections
T122	AdverseReaction 6080 6104	non-melanoma skin cancer
T123	Negation 6070 6079	excluding
T124	Factor 7729 7736	placebo
T56	DrugClass 8364 8391	immunosuppressant therapies
T66	AdverseReaction 9946 9980	worsening congestive heart failure
T67	AdverseReaction 10196 10230	worsening congestive heart failure
T127	DrugClass 12591 12603	TNF blockers
T128	Severity 13450 13471	medically significant
T129	AdverseReaction 14945 14972	formation of autoantibodies
T15	AdverseReaction 9946 9955;9982 9985	worsening CHF
T130	AdverseReaction 10196 10205;10232 10235	worsening CHF
T131	Severity 52 59	Serious
T57	AdverseReaction 11174 11189;11209 11212	reactivation of HBV
E1	AdverseReaction:T1 Hypothetical:E3
E2	AdverseReaction:T2 Hypothetical:E3
E3	DrugClass:T3
E4	AdverseReaction:T4 Hypothetical:E5
E5	Factor:T5
E6	AdverseReaction:T6 Hypothetical:E9
E7	AdverseReaction:T7 Effect:E8 Hypothetical:E9
E8	Severity:T8
E9	Factor:T9
E10	AdverseReaction:T10 Hypothetical:E11
E11	Factor:T11
E12	AdverseReaction:T12 Effect:E13 Hypothetical:E14
E13	Severity:T13
E14	Factor:T14
E16	AdverseReaction:T16 Hypothetical:E17
E17	Factor:T17
E18	AdverseReaction:T18 Hypothetical:E33
E19	AdverseReaction:T19 Hypothetical:E33
E20	AdverseReaction:T20 Hypothetical:E33
E21	AdverseReaction:T21 Hypothetical:E33
E22	AdverseReaction:T22 Hypothetical:E33
E23	AdverseReaction:T23 Hypothetical:E33
E24	AdverseReaction:T24 Hypothetical:E33
E25	AdverseReaction:T25 Hypothetical:E33
E26	AdverseReaction:T26 Hypothetical:E33
E27	AdverseReaction:T27 Hypothetical:E33
E28	AdverseReaction:T28 Hypothetical:E33
E29	AdverseReaction:T29 Hypothetical:E33
E30	AdverseReaction:T30 Hypothetical:E33
E31	AdverseReaction:T31 Hypothetical:E33
E32	AdverseReaction:T32 Hypothetical:E33
E33	DrugClass:T33
E34	AdverseReaction:T34 Hypothetical:E35
E35	Factor:T35
E36	AdverseReaction:T36
E37	AdverseReaction:T37
E38	AdverseReaction:T38 Hypothetical:E39
E39	DrugClass:T39
E40	AdverseReaction:T40
E41	AdverseReaction:T41 Hypothetical:E43
E42	AdverseReaction:T42 Hypothetical:E43
E43	DrugClass:T43
E44	AdverseReaction:T44
E45	AdverseReaction:T45
E46	AdverseReaction:T46
E47	AdverseReaction:T47
E48	AdverseReaction:T48
E49	AdverseReaction:T49
E50	AdverseReaction:T50
E51	AdverseReaction:T51 Hypothetical:E52
E52	DrugClass:T52
E53	AdverseReaction:T53
E54	AdverseReaction:T54 Negated:E124
E55	AdverseReaction:T55
E58	AdverseReaction:T58 Hypothetical2:E56
E60	AdverseReaction:T60
E61	AdverseReaction:T61
E62	AdverseReaction:T62
E63	AdverseReaction:T63 Hypothetical:E65
E64	AdverseReaction:T64 Hypothetical:E65
E65	DrugClass:T65
E70	AdverseReaction:T70
E73	AdverseReaction:T73 Hypothetical:E75
E74	AdverseReaction:T74 Hypothetical:E75
E75	DrugClass:T75
E76	AdverseReaction:T76 Hypothetical:E77
E77	Factor:T77
E78	AdverseReaction:T78
E79	AdverseReaction:T79
E80	AdverseReaction:T80
E81	AdverseReaction:T81
E82	AdverseReaction:T82
E83	AdverseReaction:T83
E84	AdverseReaction:T84
E85	AdverseReaction:T85 Hypothetical:E86
E86	DrugClass:T86
E87	AdverseReaction:T87 Hypothetical:E86
E88	AdverseReaction:T88
E89	AdverseReaction:T89 Hypothetical:E127
E90	AdverseReaction:T90 Hypothetical:E127
E91	AdverseReaction:T91 Hypothetical:E127
E92	AdverseReaction:T92 Hypothetical:E127
E93	AdverseReaction:T93
E94	AdverseReaction:T94
E95	AdverseReaction:T95
E96	AdverseReaction:T96
E97	AdverseReaction:T97 Hypothetical:E99
E98	AdverseReaction:T98 Hypothetical:E99
E99	DrugClass:T99
E100	AdverseReaction:T100
E101	AdverseReaction:T101 Effect:E128
E102	AdverseReaction:T102
E103	AdverseReaction:T103
E104	AdverseReaction:T104
E105	AdverseReaction:T105 Effect:E106 Hypothetical:E107
E106	Severity:T106
E107	DrugClass:T107
E109	AdverseReaction:T109 Effect:E110 Hypothetical:E111 Hypothetical2:E112
E110	Severity:T110
E111	Factor:T111
E112	DrugClass:T112
E113	AdverseReaction:T113 Hypothetical:E114
E114	Factor:T114
E117	AdverseReaction:T117
E119	AdverseReaction:T119
E120	AdverseReaction:T120
E121	AdverseReaction:T121
E115	AdverseReaction:T115 Hypothetical:E5
E116	AdverseReaction:T116
E118	AdverseReaction:T118 Effect:E131
E122	AdverseReaction:T122 Negated:E123
E123	Negation:T123
E124	Factor:T124
E56	DrugClass:T56
E66	AdverseReaction:T66
E67	AdverseReaction:T67 Hypothetical:E75
E127	DrugClass:T127
E128	Severity:T128
E129	AdverseReaction:T129 Hypothetical:E114
E15	AdverseReaction:T15
E130	AdverseReaction:T130
E131	Severity:T131
E57	AdverseReaction:T57
A1	CUI E1 C0024299
A2	UMLS-Preferred-Name E1 Lymphoma
A3	MEDDRA-PT E1 Lymphoma
A4	MEDDRA-PT-ID E1 10025310
A5	CUI E2 C0006826
A6	UMLS-Preferred-Name E2 Malignant Neoplasms
A7	MEDDRA-PT E2 Neoplasm malignant
A8	MEDDRA-PT-ID E2 10028997
A9	CUI E4 C0018801
A10	UMLS-Preferred-Name E4 Heart failure
A11	MEDDRA-PT E4 Cardiac failure
A12	MEDDRA-PT-ID E4 10007554
A13	CUI E6 C0002792
A14	UMLS-Preferred-Name E6 anaphylaxis
A15	MEDDRA-PT E6 Anaphylactic reaction
A16	MEDDRA-PT-ID E6 10002198
A17	LLT E6 Anaphylaxis
A18	LLT-ID E6 10002218
A19	CUI E7 C1527304
A20	UMLS-Preferred-Name E7 Allergic Reaction
A21	MEDDRA-PT E7 Hypersensitivity
A22	MEDDRA-PT-ID E7 10020751
A23	LLT E7 Allergic reaction
A24	LLT-ID E7 10001718
A25	CUI E10 C0011303
A26	UMLS-Preferred-Name E10 Demyelinating Diseases
A27	MEDDRA-PT E10 Demyelination
A28	MEDDRA-PT-ID E10 10012305
A29	LLT E10 Demyelination disorder NOS
A30	LLT-ID E10 10048425
A31	CUI E12 C3714514
A32	UMLS-Preferred-Name E12 Infection
A33	MEDDRA-PT E12 Infection
A34	MEDDRA-PT-ID E12 10021789
A35	CUI E16 C1306577
A36	UMLS-Preferred-Name E16 Death (finding)
A37	MEDDRA-PT E16 Death
A38	MEDDRA-PT-ID E16 10011906
A39	CUI E18 C0029118
A40	UMLS-Preferred-Name E18 Opportunistic Infections
A41	MEDDRA-PT E18 Opportunistic infection
A42	MEDDRA-PT-ID E18 10030901
A43	CUI E19 C0004623
A44	UMLS-Preferred-Name E19 Bacterial Infections
A45	MEDDRA-PT E19 Bacterial infection
A46	MEDDRA-PT-ID E19 10060945
A47	CUI E20 C0026918
A48	UMLS-Preferred-Name E20 Mycobacterium Infections
A49	MEDDRA-PT E20 Mycobacterial infection
A50	MEDDRA-PT-ID E20 10062207
A51	CUI E21 C1262313
A52	UMLS-Preferred-Name E21 Invasive mycosis
A53	MEDDRA-PT E21 Systemic mycosis
A54	MEDDRA-PT-ID E21 10052366
A55	LLT E21 Invasive mycosis
A56	LLT-ID E21 10062642
A57	CUI E22 C0042769
A58	UMLS-Preferred-Name E22 Virus Diseases
A59	MEDDRA-PT E22 Viral infection
A60	MEDDRA-PT-ID E22 10047461
A61	CUI E23 C0747256
A62	UMLS-Preferred-Name E23 Parasitic infection
A63	MEDDRA-PT E23 Infection parasitic
A64	MEDDRA-PT-ID E23 10021857
A65	CUI E24 C0004030
A66	UMLS-Preferred-Name E24 Aspergillosis
A67	MEDDRA-PT E24 Aspergillus infection
A68	MEDDRA-PT-ID E24 10074171
A69	LLT E24 Aspergillosis
A70	LLT-ID E24 10003488
A71	CUI E25 C0005716
A72	UMLS-Preferred-Name E25 Blastomycosis
A73	MEDDRA-PT E25 Blastomycosis
A74	MEDDRA-PT-ID E25 10005098
A75	CUI E26 C0006840
A76	UMLS-Preferred-Name E26 Candidiasis
A77	MEDDRA-PT E26 Candida infection
A78	MEDDRA-PT-ID E26 10074170
A79	LLT E26 Candidiasis
A80	LLT-ID E26 10007152
A81	CUI E27 C0009186
A82	UMLS-Preferred-Name E27 Coccidioidomycosis
A83	MEDDRA-PT E27 Coccidioidomycosis
A84	MEDDRA-PT-ID E27 10009825
A85	CUI E28 C0019655
A86	UMLS-Preferred-Name E28 Histoplasmosis
A87	MEDDRA-PT E28 Histoplasmosis
A88	MEDDRA-PT-ID E28 10020141
A89	CUI E29 C0023240
A90	UMLS-Preferred-Name E29 Legionellosis
A91	MEDDRA-PT E29 Legionella infection
A92	MEDDRA-PT-ID E29 10061266
A93	CUI E30 C0023860
A94	UMLS-Preferred-Name E30 Listeriosis
A95	MEDDRA-PT E30 Listeriosis
A96	MEDDRA-PT-ID E30 10024641
A97	CUI E31 C1535939
A98	UMLS-Preferred-Name E31 Pneumocystis jiroveci pneumonia
A99	MEDDRA-PT E31 Pneumocystis jirovecii pneumonia
A100	MEDDRA-PT-ID E31 10073755
A101	LLT E31 Pneumocystosis
A102	LLT-ID E31 10035662
A103	CUI E32 C0041296
A104	UMLS-Preferred-Name E32 Tuberculosis
A105	MEDDRA-PT E32 Tuberculosis
A106	MEDDRA-PT-ID E32 10044755
A107	CUI E34 C3714514
A108	UMLS-Preferred-Name E34 Infection
A109	MEDDRA-PT E34 Infection
A110	MEDDRA-PT-ID E34 10021789
A111	CUI E36 C0275965
A112	UMLS-Preferred-Name E36 Reactivation tuberculosis
A113	MEDDRA-PT E36 Tuberculosis
A114	MEDDRA-PT-ID E36 10044755
A115	LLT E36 Tuberculosis reactivated
A116	LLT-ID E36 10045025
A117	CUI E37 C0041296
A118	UMLS-Preferred-Name E37 Tuberculosis
A119	MEDDRA-PT E37 Tuberculosis
A120	MEDDRA-PT-ID E37 10044755
A121	LLT E37 Infection tuberculosis
A122	LLT-ID E37 10021870
A123	CUI E38 C0006826
A124	UMLS-Preferred-Name E38 Malignant Neoplasms
A125	MEDDRA-PT E38 Neoplasm malignant
A126	MEDDRA-PT-ID E38 10028997
A127	CUI E40 C0006826
A128	UMLS-Preferred-Name E40 Malignant Neoplasms
A129	MEDDRA-PT E40 Neoplasm malignant
A130	MEDDRA-PT-ID E40 10028997
A131	CUI E41 C0006826
A132	UMLS-Preferred-Name E41 Malignant Neoplasms
A133	MEDDRA-PT E41 Neoplasm malignant
A134	MEDDRA-PT-ID E41 10028997
A135	CUI E42 C1306577
A136	UMLS-Preferred-Name E42 Death (finding)
A137	MEDDRA-PT E42 Death
A138	MEDDRA-PT-ID E42 10011906
A139	CUI E44 C0024299
A140	UMLS-Preferred-Name E44 Lymphoma
A141	MEDDRA-PT E44 Lymphoma
A142	MEDDRA-PT-ID E44 10025310
A143	CUI E45 C0019829
A144	UMLS-Preferred-Name E45 Hodgkin Disease
A145	MEDDRA-PT E45 Hodgkin's disease
A146	MEDDRA-PT-ID E45 10020206
A147	LLT E45 Hodgkin's lymphoma
A148	LLT-ID E45 10020328
A149	CUI E46 C0024305
A150	UMLS-Preferred-Name E46 Lymphoma, Non-Hodgkin
A151	MEDDRA-PT E46 Non-Hodgkin's lymphoma
A152	MEDDRA-PT-ID E46 10029547
A153	CUI E47 C0006826
A154	UMLS-Preferred-Name E47 Malignant Neoplasms
A155	MEDDRA-PT E47 Neoplasm malignant
A156	MEDDRA-PT-ID E47 10028997
A157	CUI E48 C0006826
A158	UMLS-Preferred-Name E48 Malignant Neoplasms
A159	MEDDRA-PT E48 Neoplasm malignant
A160	MEDDRA-PT-ID E48 10028997
A161	CUI E49 C0006826
A162	UMLS-Preferred-Name E49 Malignant Neoplasms
A163	MEDDRA-PT E49 Neoplasm malignant
A164	MEDDRA-PT-ID E49 10028997
A165	CUI E50 C0006826
A166	UMLS-Preferred-Name E50 Malignant Neoplasms
A167	MEDDRA-PT E50 Neoplasm malignant
A168	MEDDRA-PT-ID E50 10028997
A169	CUI E51 C0024299
A170	UMLS-Preferred-Name E51 Lymphoma
A171	MEDDRA-PT E51 Lymphoma
A172	MEDDRA-PT-ID E51 10025310
A173	CUI E53 C0024299
A174	UMLS-Preferred-Name E53 Lymphoma
A175	MEDDRA-PT E53 Lymphoma
A176	MEDDRA-PT-ID E53 10025310
A177	CUI E54 C0019829
A178	UMLS-Preferred-Name E54 Hodgkin Disease
A179	MEDDRA-PT E54 Hodgkin's disease
A180	MEDDRA-PT-ID E54 10020206
A181	LLT E54 Hodgkin's lymphoma
A182	LLT-ID E54 10020328
A183	CUI E55 C0024299
A184	UMLS-Preferred-Name E55 Lymphoma
A185	MEDDRA-PT E55 Lymphoma
A186	MEDDRA-PT-ID E55 10025310
A187	CUI E58 C0024299
A188	UMLS-Preferred-Name E58 Lymphoma
A189	MEDDRA-PT E58 Lymphoma
A190	MEDDRA-PT-ID E58 10025310
A191	CUI E60 C1333984
A192	UMLS-Preferred-Name E60 Hepatosplenic T-cell lymphoma
A193	MEDDRA-PT E60 Hepatosplenic T-cell lymphoma
A194	MEDDRA-PT-ID E60 10066957
A195	CUI E61 C1333984
A196	UMLS-Preferred-Name E61 Hepatosplenic T-cell lymphoma
A197	MEDDRA-PT E61 Hepatosplenic T-cell lymphoma
A198	MEDDRA-PT-ID E61 10066957
A199	CUI E62 C1306577
A200	UMLS-Preferred-Name E62 Death (finding)
A201	MEDDRA-PT E62 Death
A202	MEDDRA-PT-ID E62 10011906
A203	CUI E63 C1279296
A204	UMLS-Preferred-Name E63 Chronic leukemia (category)
A205	MEDDRA-PT E63 Chronic leukaemia
A206	MEDDRA-PT-ID E63 10008943
A207	LLT E63 Chronic leukemia
A208	LLT-ID E63 10008948
A209	CUI E64 C0085669
A210	UMLS-Preferred-Name E64 Acute leukemia
A211	MEDDRA-PT E64 Acute leukaemia
A212	MEDDRA-PT-ID E64 10000830
A213	LLT E64 Acute leukemia
A214	LLT-ID E64 10000835
A215	CUI E70 C0742752
A216	UMLS-Preferred-Name E70 CONGESTIVE HEART FAILURE NEW ONSET
A217	MEDDRA-PT E70 Cardiac failure congestive
A218	MEDDRA-PT-ID E70 10007559
A219	LLT E70 CHF
A220	LLT-ID E70 10008502
A221	CUI E73 C1306577
A222	UMLS-Preferred-Name E73 Death (finding)
A223	MEDDRA-PT E73 Death
A224	MEDDRA-PT-ID E73 10011906
A225	CUI E74 C0018802
A226	UMLS-Preferred-Name E74 Congestive heart failure
A227	MEDDRA-PT E74 Cardiac failure congestive
A228	MEDDRA-PT-ID E74 10007559
A229	LLT E74 Congestive heart failure
A230	LLT-ID E74 10010684
A231	CUI E76 C0020517
A232	UMLS-Preferred-Name E76 Hypersensitivity
A233	MEDDRA-PT E76 Hypersensitivity
A234	MEDDRA-PT-ID E76 10020751
A235	LLT E76 Hypersensitivity reaction
A236	LLT-ID E76 10020756
A237	CUI E78 C0002994
A238	UMLS-Preferred-Name E78 Angioedema
A239	MEDDRA-PT E78 Angioedema
A240	MEDDRA-PT-ID E78 10002424
A241	CUI E79 C0013404
A242	UMLS-Preferred-Name E79 Dyspnea
A243	MEDDRA-PT E79 Dyspnoea
A244	MEDDRA-PT-ID E79 10013968
A245	LLT E79 Dyspnea
A246	LLT-ID E79 10013963
A247	CUI E80 C0020649
A248	UMLS-Preferred-Name E80 Hypotension
A249	MEDDRA-PT E80 Hypotension
A250	MEDDRA-PT-ID E80 10021097
A251	CUI E81 C0015230
A252	UMLS-Preferred-Name E81 Exanthema
A253	MEDDRA-PT E81 Rash
A254	MEDDRA-PT-ID E81 10037844
A255	CUI E82 C0036830
A256	UMLS-Preferred-Name E82 Serum Sickness
A257	MEDDRA-PT E82 Serum sickness
A258	MEDDRA-PT-ID E82 10040400
A259	CUI E83 C0042109
A260	UMLS-Preferred-Name E83 Urticaria
A261	MEDDRA-PT E83 Urticaria
A262	MEDDRA-PT-ID E83 10046735
A263	CUI E84 C1142420
A264	UMLS-Preferred-Name E84 Hepatitis B reactivation
A265	MEDDRA-PT E84 Hepatitis B
A266	MEDDRA-PT-ID E84 10019731
A267	LLT E84 Hepatitis B reactivation
A268	LLT-ID E84 10058827
A269	CUI E85 C1142420
A270	UMLS-Preferred-Name E85 Hepatitis B reactivation
A271	MEDDRA-PT E85 Hepatitis B
A272	MEDDRA-PT-ID E85 10019731
A273	LLT E85 Hepatitis B reactivation
A274	LLT-ID E85 10058827
A275	CUI E87 C1306577
A276	UMLS-Preferred-Name E87 Death (finding)
A277	MEDDRA-PT E87 Death
A278	MEDDRA-PT-ID E87 10011906
A279	CUI E88 C1142420
A280	UMLS-Preferred-Name E88 Hepatitis B reactivation
A281	MEDDRA-PT E88 Hepatitis B
A282	MEDDRA-PT-ID E88 10019731
A283	LLT E88 Hepatitis B reactivation
A284	LLT-ID E88 10058827
A285	CUI E89 C0011302
A286	UMLS-Preferred-Name E89 Demyelinating disease of central nervous system
A287	MEDDRA-PT E89 Demyelination
A288	MEDDRA-PT-ID E89 10012305
A289	LLT E89 Demyelinating disease of central nervous system, unspecified
A290	LLT-ID E89 10012301
A291	CUI E90 C0026769
A292	UMLS-Preferred-Name E90 Multiple Sclerosis
A293	MEDDRA-PT E90 Multiple sclerosis
A294	MEDDRA-PT-ID E90 10028245
A295	CUI E91 C0751452
A296	UMLS-Preferred-Name E91 Autoimmune Demyelinating Disease, Peripheral
A297	MEDDRA-PT E91 Autoimmune demyelinating disease
A298	MEDDRA-PT-ID E91 10075688
A299	CUI E92 C0018378
A300	UMLS-Preferred-Name E92 Guillain-Barre Syndrome
A301	MEDDRA-PT E92 Guillain-Barre syndrome
A302	MEDDRA-PT-ID E92 10018767
A303	CUI E93 C0027765
A304	UMLS-Preferred-Name E93 nervous system disorder
A305	MEDDRA-PT E93 Nervous system disorder
A306	MEDDRA-PT-ID E93 10029202
A307	CUI E94 C0014544
A308	UMLS-Preferred-Name E94 Epilepsy
A309	MEDDRA-PT E94 Seizure
A310	MEDDRA-PT-ID E94 10039906
A311	LLT E94 Convulsion disorder
A312	LLT-ID E94 10010907
A313	CUI E95 C0029134
A314	UMLS-Preferred-Name E95 Optic Neuritis
A315	MEDDRA-PT E95 Optic neuritis
A316	MEDDRA-PT-ID E95 10030942
A317	CUI E96 C0031117
A318	UMLS-Preferred-Name E96 Peripheral Neuropathy
A319	MEDDRA-PT E96 Neuropathy peripheral
A320	MEDDRA-PT-ID E96 10029331
A321	CUI E97 C0030312
A322	UMLS-Preferred-Name E97 Pancytopenia
A323	MEDDRA-PT E97 Pancytopenia
A324	MEDDRA-PT-ID E97 10033661
A325	CUI E98 C0002874
A326	UMLS-Preferred-Name E98 Aplastic Anemia
A327	MEDDRA-PT E98 Aplastic anaemia
A328	MEDDRA-PT-ID E98 10002967
A329	LLT E98 Aplastic anemia
A330	LLT-ID E98 10002969
A331	CUI E100 C0018939
A332	UMLS-Preferred-Name E100 Hematological Disease
A333	MEDDRA-PT E100 Blood disorder
A334	MEDDRA-PT-ID E100 10061590
A335	CUI E101 C0010828
A336	UMLS-Preferred-Name E101 Cytopenia
A337	MEDDRA-PT E101 Cytopenia
A338	MEDDRA-PT-ID E101 10066274
A339	CUI E102 C0023530
A340	UMLS-Preferred-Name E102 Leukopenia
A341	MEDDRA-PT E102 Leukopenia
A342	MEDDRA-PT-ID E102 10024384
A343	CUI E103 C0030312
A344	UMLS-Preferred-Name E103 Pancytopenia
A345	MEDDRA-PT E103 Pancytopenia
A346	MEDDRA-PT-ID E103 10033661
A347	CUI E104 C0040034
A348	UMLS-Preferred-Name E104 Thrombocytopenia
A349	MEDDRA-PT E104 Thrombocytopenia
A350	MEDDRA-PT-ID E104 10043554
A351	CUI E105 C3714514
A352	UMLS-Preferred-Name E105 Infection
A353	MEDDRA-PT E105 Infection
A354	MEDDRA-PT-ID E105 10021789
A355	CUI E109 C3714514
A356	UMLS-Preferred-Name E109 Infection
A357	MEDDRA-PT E109 Infection
A358	MEDDRA-PT-ID E109 10021789
A359	CUI E113 C0919715
A360	UMLS-Preferred-Name E113 Lupus-like syndrome
A361	MEDDRA-PT E113 Lupus-like syndrome
A362	MEDDRA-PT-ID E113 10050551
A363	CUI E117 C1262313
A364	UMLS-Preferred-Name E117 Invasive mycosis
A365	MEDDRA-PT E117 Systemic mycosis
A366	MEDDRA-PT-ID E117 10052366
A367	LLT E117 Invasive mycosis
A368	LLT-ID E117 10062642
A369	CUI E119 C0010828
A370	UMLS-Preferred-Name E119 Cytopenia
A371	MEDDRA-PT E119 Cytopenia
A372	MEDDRA-PT-ID E119 10066274
A373	CUI E120 C0030312
A374	UMLS-Preferred-Name E120 Pancytopenia
A375	MEDDRA-PT E120 Pancytopenia
A376	MEDDRA-PT-ID E120 10033661
A377	CUI E121 C0919715
A378	UMLS-Preferred-Name E121 Lupus-like syndrome
A379	MEDDRA-PT E121 Lupus-like syndrome
A380	MEDDRA-PT-ID E121 10050551
A381	CUI E115 C0235875
A382	UMLS-Preferred-Name E115 Cardiac failure aggravated
A383	MEDDRA-PT E115 Cardiac failure
A384	MEDDRA-PT-ID E115 10007554
A385	LLT E115 Cardiac failure aggravated
A386	LLT-ID E115 10007557
A387	CUI E116 C1142420
A388	UMLS-Preferred-Name E116 Hepatitis B reactivation
A389	MEDDRA-PT E116 Hepatitis B
A390	MEDDRA-PT-ID E116 10019731
A391	LLT E116 Hepatitis B reactivation
A392	LLT-ID E116 10058827
A393	CUI E118 C3714514
A394	UMLS-Preferred-Name E118 Infection
A395	MEDDRA-PT E118 Infection
A396	MEDDRA-PT-ID E118 10021789
A397	CUI E122 C0699893
A398	UMLS-Preferred-Name E122 Skin carcinoma
A399	MEDDRA-PT E122 Skin cancer
A400	MEDDRA-PT-ID E122 10040808
A401	LLT E122 Cancer of skin (excl melanoma)
A402	LLT-ID E122 10007116
A403	CUI E66 C3532952
A404	UMLS-Preferred-Name E66 Exacerbation of congestive heart failure
A405	MEDDRA-PT E66 Cardiac failure congestive
A406	MEDDRA-PT-ID E66 10007559
A407	LLT E66 Congestive cardiac failure aggravated
A408	LLT-ID E66 10048565
A409	CUI E67 C3532952
A410	UMLS-Preferred-Name E67 Exacerbation of congestive heart failure
A411	MEDDRA-PT E67 Cardiac failure congestive
A412	MEDDRA-PT-ID E67 10007559
A413	LLT E67 Congestive cardiac failure aggravated
A414	LLT-ID E67 10048565
A415	CUI E129 C0004366
A416	UMLS-Preferred-Name E129 Autoimmune Response
A417	MEDDRA-PT E129 Autoimmune disorder
A418	MEDDRA-PT-ID E129 10061664
A419	CUI E15 C3532952
A420	UMLS-Preferred-Name E15 Exacerbation of congestive heart failure
A421	MEDDRA-PT E15 Cardiac failure congestive
A422	MEDDRA-PT-ID E15 10007559
A423	LLT E15 Congestive cardiac failure aggravated
A424	LLT-ID E15 10048565
A425	CUI E130 C3532952
A426	UMLS-Preferred-Name E130 Exacerbation of congestive heart failure
A427	MEDDRA-PT E130 Cardiac failure congestive
A428	MEDDRA-PT-ID E130 10007559
A429	LLT E130 Congestive cardiac failure aggravated
A430	LLT-ID E130 10048565
A431	CUI E57 C1142420
A432	UMLS-Preferred-Name E57 Hepatitis B reactivation
A433	MEDDRA-PT E57 Hepatitis B
A434	MEDDRA-PT-ID E57 10019731
A435	LLT E57 Hepatitis B reactivation
A436	LLT-ID E57 10058827
